Regen BioPharma Inc (RGBP) stock
RGBPOTCPharmaceutical PreparationsFiscal year ends September 30Also trades as RGBPP
$0.00+0.00 (+50.00%)
Close on Oct 19, 2026Market cap $92.33KP/E –Yield –
Regen BioPharma enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Regen BioPharma's enterprise value was $169.26K on Oct 19, 2026, against $407.35K a year earlier. Over the last 5 years it ranged from $891 to $54.16B, with a median of $1.52M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $169.26K | -23.7% |
| 2025 | Dec 31, 2025 | $221.82K | -39.9% |
| 2024 | Dec 31, 2024 | $368.94K | -78.2% |
| 2023 | Dec 29, 2023 | $1.69M | -82.6% |
| 2022 | Dec 30, 2022 | $9.76M | -100.0% |
| 2021 | Dec 31, 2021 | $47.80B | +3871.0% |
| 2020 | Dec 31, 2020 | $1.20B | +1237.6% |
| 2019 | Dec 31, 2019 | $89.99M | -76.2% |
| 2018 | Dec 31, 2018 | $378.65M | -92.9% |
| 2017 | Dec 29, 2017 | $5.34B | -37.9% |
| 2016 | Dec 30, 2016 | $8.60B | -35.6% |
| 2015 | Dec 31, 2015 | $13.34B | +146.2% |
| 2014 | Dec 31, 2014 | $5.42B | – |
See a number that looks wrong?